CRISPR Therapeutics Appoints Dr. Tony W. Ho to Head Research & Development – GlobeNewswire (press release)
|
CRISPR Therapeutics Appoints Dr. Tony W. Ho to Head Research & Development
GlobeNewswire (press release) ZUG, Switzerland and CAMBRIDGE, Mass., Aug. 01, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announces the … |
